Literature DB >> 10199328

Advances in cancer pain.

K M Foley1.   

Abstract

Advances in cancer pain research and management are an example of the advances that have occurred within the field of neuro-oncology, the medical discipline that includes the diagnosis and treatment of primary central nervous system neoplasms, metastatic and nonmetastatic neurological complications of cancer originating outside the nervous system, and pain associated with cancer. Progress in the diagnosis and treatment of cancer, coupled with advances in our understanding of the anatomy, physiology, pharmacology, and psychology of pain perception, has led to improved care of the patient with pain of malignant origin. Currently, specialized methods of cancer diagnosis and treatment provide the most direct approach to treating cancer pain by treating the cause of the pain. Yet, before the introduction of successful antitumor therapy, when treatment of the cause of the pain has failed or when injury to bone, soft tissue, or nerve has occurred as a result of therapy, appropriate pain management is essential.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199328     DOI: 10.1001/archneur.56.4.413

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  18 in total

Review 1.  Recent advances: palliative care.

Authors:  J A Billings
Journal:  BMJ       Date:  2000-09-02

2.  Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain.

Authors:  M J Schwei; P Honore; S D Rogers; J L Salak-Johnson; M P Finke; M L Ramnaraine; D R Clohisy; P W Mantyh
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

Review 3.  P2X receptors: New players in cancer pain.

Authors:  Alessia Franceschini; Elena Adinolfi
Journal:  World J Biol Chem       Date:  2014-11-26

4.  A randomized trial of nature scenery and sounds versus urban scenery and sounds to reduce pain in adults undergoing bone marrow aspirate and biopsy.

Authors:  Noah Lechtzin; Anne M Busse; Michael T Smith; Stuart Grossman; Suzanne Nesbit; Gregory B Diette
Journal:  J Altern Complement Med       Date:  2010-09       Impact factor: 2.579

5.  Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy.

Authors:  Joel B Epstein; Diana J Wilkie; Dena J Fischer; Young-Ok Kim; Dana Villines
Journal:  Head Neck Oncol       Date:  2009-07-14

Review 6.  Animal models of cancer pain.

Authors:  Cholawat Pacharinsak; Alvin Beitz
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

7.  Interleukin 1beta facilitates bone cancer pain in rats by enhancing NMDA receptor NR-1 subunit phosphorylation.

Authors:  R-X Zhang; B Liu; A Li; L Wang; K Ren; J-T Qiao; B M Berman; L Lao
Journal:  Neuroscience       Date:  2008-05-07       Impact factor: 3.590

8.  Activation of c-jun N-terminal kinase in spinal cord contributes to breast cancer induced bone pain in rats.

Authors:  Xiao-Wei Wang; Shan Hu; Qi-Liang Mao-Ying; Qian Li; Chang-Jiang Yang; Hui Zhang; Wen-Li Mi; Gen-Cheng Wu; Yan-Qing Wang
Journal:  Mol Brain       Date:  2012-06-09       Impact factor: 4.041

9.  Facts and an open mind should guide clinical practice.

Authors:  A Carver; K Foley
Journal:  Curr Neurol Neurosci Rep       Date:  2001-03       Impact factor: 6.030

Review 10.  Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology.

Authors:  Kyriaki Mystakidou; Eleni Tsilika; Marinos Tsiatas; Lambros Vlahos
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.